Guerbet SA (EPA:GBT)
France
· Delayed Price · Currency is EUR 19.04
+0.72 (3.93%)
Apr 1, 2025, 12:41 PM CET
Guerbet Revenue
Guerbet had revenue of 424.92M EUR in the half year ending June 30, 2024, with 13.56% growth. This brings the company's revenue in the last twelve months to 840.79M, up 8.48% year-over-year. In the year 2023, Guerbet had annual revenue of 795.65M with 3.40% growth.
Revenue (ttm)
840.79M
Revenue Growth
+8.48%
P/S Ratio
0.27
Revenue / Employee
287.94K
Employees
2,920
Market Cap
231.00M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 795.65M | 26.16M | 3.40% |
| Dec 31, 2022 | 769.50M | 33.59M | 4.56% |
| Dec 31, 2021 | 735.91M | 19.24M | 2.68% |
| Dec 31, 2020 | 716.67M | -102.33M | -12.49% |
| Dec 31, 2019 | 819.00M | 24.39M | 3.07% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sanofi | 44.29B |
| EssilorLuxottica Société anonyme | 26.51B |
| Sartorius Stedim Biotech | 2.78B |
| bioMérieux | 3.98B |
| Eurofins Scientific SE | 6.95B |
| Ipsen | 3.57B |
| Virbac | 1.40B |
| emeis Société anonyme | 5.43B |